Jpmorgan Chase & CO Sop Hi A Genetics Sa Transaction History

Jpmorgan Chase & CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Dec 26, 2024	BUY	$2.5 - $4.87 $2,202 - $4,290	881 New	881 $4,000
Q4 2023 Feb 12, 2024	SELL	$2.5 - $4.87 $74,100 - $144,346	-29,640 Reduced 97.11%	881 $4,000
Q3 2023 Nov 14, 2023	SELL	$2.3 - $4.58 $12,886 - $25,661	-5,603 Reduced 15.51%	30,521 $77,000
Q2 2023 Aug 11, 2023	SELL	$3.84 - $5.3 $71,439 - $98,601	-18,604 Reduced 33.99%	36,124 $161,000
Q1 2023 May 11, 2023	BUY	$1.98 - $5.49 $46,205 - $128,114	23,336 Added 74.34%	54,728 $271,000
Q4 2022 Feb 13, 2023	BUY	$1.71 - $2.98 $51,997 - $90,615	30,408 Added 3090.24%	31,392 $65,000
Q3 2022 Nov 14, 2022	BUY	$2.63 - $5.1 $2,587 - $5,018	984 New	984 $3,000
Q1 2022 May 11, 2022	SELL	$7.31 - $15.6 $2,507 - $5,350	-343 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$12.35 - $18.8 $1,852 - $2,820	-150 Reduced 30.43%	343 $5,000
Q3 2021 Nov 12, 2021	BUY	$15.18 - $19.77 $7,483 - $9,746	493 New	493 $9,000

18.6M

5.9K

300

Ticker SOPH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 64,153,700
Market Cap $185M
Description
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.